Nephros Inc. Common Stock (NEPH)

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as we…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

36

Website

www.nephros.com/

Fundamentals

1-day range

$3.62$4.6

Market cap

$38.98M

P/E (trailing)

64.38

P/E (forward)

21.05

EPS (trailing)

$0.07

Dividend yield

—

Beta

1.64

Avg. volume

18.2K

Dividend pay date

July 10, 2019

Forecasts

3 analyst ratings

Nephros Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NEPH

  Nephros Inc. Common Stock

  $4.61

  ▲ 6.96%
  Market cap $38.98MP/E 64.38
  $2.66$6.42
• TELA

  TELA Bio Inc. Common Stock

  $0.6748

  ▲ 3.82%
  Market cap $38.50MP/E —
  $0.5011$1.91
• ARAY

  Accuray Incorporated Common Stock

  $0.2772

  ▲ 6.62%
  Market cap $33.63MP/E —
  $0.22$2.1
• SRTS

  Sensus Healthcare Inc. Common Stock

  $3.56

  ▲ 5.64%
  Market cap $49.06MP/E —
  $2.66$5.49
• BEAT

  Heartbeam Inc. Common Stock

  $0.4693

  ▼ 3.44%
  Market cap $28.33MP/E —
  $0.471$4
• BDMD

  Baird Medical Investment Holdings Ltd Ordinary Share

  $1.12

  ▼ 4.27%
  Market cap $49.81MP/E —
  $0.757$3.7
• SNWV

  SANUWAVE Health Inc. Common Stock

  $4.64

  ▼ 0.43%
  Market cap $51.59MP/E 2.56
  $4.5$44.94

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Industrials Stocks Moving In Friday's Pre-Market Session
  Benzinga · 8/28/2026
• Nephros, Inc. (NEPH) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• 12 Industrials Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/6/2026
• Nephros Q2 EPS $0.11 Beats $0.00 Estimate, Sales $6.017M Beat $4.994M Estimate
  Benzinga · 8/6/2026

• Amron Arthur H · August 12, 2026 · Grant

  2.4K
• Amron Arthur H · May 11, 2026 · Grant

  3.6K
• Banks Robert R. Jr. · March 23, 2026 · Option Exercise

  120.0K @ $1.44
• Krandel Judy · March 23, 2026 · Option Exercise

  68.9K @ $1.71
• Amron Arthur H · March 16, 2026 · Grant

  3.6K
• Krandel Judy · March 16, 2026 · Grant

  4.0K

Institutional Ownership

March 31, 2026

Total shares held

5.33M

Total value held

$15.89M

Institutional holders

26